Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Jeffrey Swigris

Concepts (324)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Idiopathic Pulmonary Fibrosis
46
2019
500
8.920
Why?
Lung Diseases, Interstitial
39
2019
495
6.340
Why?
Pulmonary Fibrosis
19
2019
321
5.170
Why?
Quality of Life
30
2019
2343
3.840
Why?
Oxygen Inhalation Therapy
10
2019
127
3.370
Why?
Dyspnea
18
2019
212
3.330
Why?
Surveys and Questionnaires
29
2019
4595
2.550
Why?
Connective Tissue Diseases
13
2019
71
2.510
Why?
Vital Capacity
25
2019
254
2.050
Why?
Lymphangioleiomyomatosis
4
2015
27
1.460
Why?
Pyridones
8
2018
122
1.350
Why?
Anti-Inflammatory Agents, Non-Steroidal
8
2018
296
1.330
Why?
Walking
7
2013
422
1.290
Why?
Lung
17
2018
3521
1.160
Why?
Aged
56
2019
18969
1.140
Why?
Arthritis, Rheumatoid
7
2018
1002
1.120
Why?
Patients
3
2018
163
1.070
Why?
Respiratory Function Tests
16
2019
522
1.070
Why?
Middle Aged
65
2019
26605
1.060
Why?
Research Design
5
2016
919
1.040
Why?
Health Care Costs
3
2018
381
1.010
Why?
Exercise Test
8
2018
547
0.980
Why?
Alveolitis, Extrinsic Allergic
4
2019
83
0.980
Why?
Health Status Indicators
4
2014
155
0.980
Why?
Humans
117
2019
114045
0.950
Why?
Sarcoidosis
4
2016
133
0.870
Why?
Male
74
2019
55396
0.860
Why?
Female
77
2019
59324
0.840
Why?
Patient Outcome Assessment
2
2014
122
0.830
Why?
Mycophenolic Acid
4
2016
76
0.820
Why?
Patient Reported Outcome Measures
4
2018
251
0.800
Why?
Severity of Illness Index
16
2018
2537
0.780
Why?
Internet
2
2016
591
0.770
Why?
Exercise Tolerance
3
2018
212
0.760
Why?
Oxygen
4
2018
851
0.730
Why?
Disease Progression
14
2019
2371
0.730
Why?
Forced Expiratory Volume
10
2017
471
0.700
Why?
Undifferentiated Connective Tissue Diseases
1
2019
1
0.660
Why?
Qualitative Research
4
2017
919
0.620
Why?
Indoles
2
2018
300
0.600
Why?
Cough
4
2019
107
0.580
Why?
Emphysema
1
2018
106
0.580
Why?
Lung Diseases
3
2015
690
0.550
Why?
Chronic Disease
4
2018
1577
0.550
Why?
Pulmonary Medicine
2
2015
69
0.550
Why?
Lung Transplantation
1
2019
244
0.550
Why?
Psychometrics
8
2017
608
0.540
Why?
Immunosuppressive Agents
4
2016
641
0.540
Why?
Heart Rate
2
2011
710
0.530
Why?
Ambulatory Care
2
2018
479
0.510
Why?
Pulmonary Emphysema
1
2018
267
0.510
Why?
Idiopathic Interstitial Pneumonias
6
2017
46
0.500
Why?
Information Seeking Behavior
1
2016
35
0.500
Why?
Narration
1
2016
44
0.500
Why?
Longitudinal Studies
8
2019
2384
0.470
Why?
Biomedical Research
2
2018
582
0.460
Why?
Kaplan-Meier Estimate
8
2018
813
0.460
Why?
Fatigue
6
2019
294
0.460
Why?
Caregivers
3
2017
713
0.460
Why?
Autoimmunity
2
2019
812
0.450
Why?
Autoimmune Diseases
3
2016
381
0.450
Why?
Reproducibility of Results
11
2019
2764
0.450
Why?
Patient-Centered Care
1
2018
470
0.430
Why?
Social Support
2
2019
528
0.430
Why?
Social Media
1
2016
131
0.430
Why?
Antitussive Agents
1
2013
8
0.420
Why?
Pulmonary Disease, Chronic Obstructive
2
2019
907
0.420
Why?
Tomography, X-Ray Computed
12
2018
2272
0.420
Why?
Motivation
1
2017
488
0.420
Why?
Thalidomide
1
2013
28
0.420
Why?
Lung Neoplasms
3
2014
2159
0.420
Why?
Prognosis
12
2018
3315
0.410
Why?
Bronchiolitis Obliterans
1
2013
66
0.410
Why?
United States
21
2019
12137
0.410
Why?
Follow-Up Studies
9
2018
4392
0.400
Why?
Aged, 80 and over
16
2017
6306
0.400
Why?
Patient Participation
1
2015
348
0.400
Why?
Survival Rate
6
2018
1638
0.400
Why?
Bronchial Diseases
1
2012
35
0.390
Why?
Treatment Outcome
16
2018
9049
0.380
Why?
Health Knowledge, Attitudes, Practice
2
2018
1168
0.380
Why?
Hospitalization
3
2017
1762
0.370
Why?
Quality Indicators, Health Care
1
2014
285
0.370
Why?
Adult
31
2019
30375
0.360
Why?
Pulmonary Diffusing Capacity
6
2017
60
0.360
Why?
Health Status
5
2019
716
0.360
Why?
Retrospective Studies
21
2019
12521
0.360
Why?
Multivariate Analysis
5
2017
1422
0.350
Why?
Peptides, Cyclic
1
2012
252
0.350
Why?
Motor Activity
1
2014
635
0.340
Why?
Endothelins
1
2010
61
0.330
Why?
Cause of Death
6
2019
362
0.330
Why?
Scleroderma, Systemic
3
2017
90
0.330
Why?
Gastroesophageal Reflux
1
2012
229
0.330
Why?
Activities of Daily Living
3
2018
348
0.320
Why?
Pulmonary Embolism
1
2011
180
0.320
Why?
Autoantibodies
4
2015
1347
0.320
Why?
Sleep Apnea, Obstructive
1
2012
195
0.320
Why?
TRPP Cation Channels
1
2009
63
0.310
Why?
Amino Acyl-tRNA Synthetases
3
2016
28
0.300
Why?
Endothelin-1
1
2010
168
0.300
Why?
Polycystic Kidney Diseases
1
2009
55
0.300
Why?
Randomized Controlled Trials as Topic
5
2017
1204
0.290
Why?
Proportional Hazards Models
3
2017
1078
0.280
Why?
Prevalence
5
2018
2247
0.280
Why?
Hypertension, Pulmonary
3
2017
1736
0.270
Why?
Mortality
4
2019
283
0.270
Why?
Tumor Suppressor Proteins
1
2009
283
0.270
Why?
Biopsy
7
2016
1024
0.270
Why?
Sex Distribution
3
2012
336
0.270
Why?
Quality Improvement
1
2014
944
0.270
Why?
Cost of Illness
3
2018
254
0.260
Why?
Double-Blind Method
6
2017
1656
0.260
Why?
Lupus Erythematosus, Systemic
1
2008
220
0.250
Why?
Thrombosis
1
2008
295
0.230
Why?
Databases, Factual
3
2019
1125
0.230
Why?
Prospective Studies
8
2019
6195
0.230
Why?
Time Factors
7
2019
6077
0.230
Why?
Vascular Endothelial Growth Factor D
2
2013
12
0.220
Why?
Oxygen Consumption
2
2017
587
0.220
Why?
Myositis
2
2016
44
0.210
Why?
Diagnosis, Differential
6
2016
1331
0.210
Why?
Palliative Care
2
2019
641
0.200
Why?
Incidence
3
2018
2314
0.190
Why?
Patient Satisfaction
2
2016
571
0.190
Why?
Focus Groups
3
2016
378
0.180
Why?
Sex Factors
5
2016
1706
0.180
Why?
Registries
3
2019
1764
0.180
Why?
Age Distribution
2
2012
341
0.180
Why?
Cohort Studies
5
2019
4883
0.180
Why?
Logistic Models
4
2019
1829
0.170
Why?
Analysis of Variance
3
2015
1218
0.170
Why?
Survival Analysis
3
2017
1206
0.170
Why?
Linear Models
3
2019
768
0.170
Why?
Walk Test
2
2017
52
0.170
Why?
Antibodies, Antinuclear
4
2016
58
0.170
Why?
Exercise
3
2019
1642
0.170
Why?
Sensitivity and Specificity
3
2015
1690
0.170
Why?
Risk Factors
7
2017
8614
0.160
Why?
Chi-Square Distribution
2
2011
492
0.160
Why?
Anxiety
3
2019
843
0.160
Why?
Pulmonologists
1
2018
13
0.160
Why?
Insurance Claim Review
1
2018
68
0.150
Why?
Accelerometry
2
2019
73
0.150
Why?
Cross-Sectional Studies
4
2019
4402
0.150
Why?
Cellular Senescence
1
2019
151
0.150
Why?
Attitude to Health
2
2014
398
0.140
Why?
Weight-Bearing
1
2018
164
0.140
Why?
Germany
1
2017
84
0.140
Why?
Sulfonamides
2
2010
444
0.140
Why?
Antihypertensive Agents
2
2010
428
0.140
Why?
Medicare
2
2018
661
0.140
Why?
Perception
1
2019
309
0.130
Why?
Host-Pathogen Interactions
1
2019
295
0.130
Why?
Common Variable Immunodeficiency
1
2016
25
0.130
Why?
Tidal Volume
1
2016
75
0.130
Why?
Muscle Strength
2
2015
271
0.130
Why?
Granuloma
1
2016
82
0.130
Why?
Cyclophosphamide
1
2016
214
0.130
Why?
Interviews as Topic
2
2016
575
0.130
Why?
Home Care Services
1
2018
219
0.130
Why?
Patient Education as Topic
2
2019
666
0.130
Why?
Health Policy
1
2018
330
0.130
Why?
Physical Conditioning, Human
1
2015
27
0.120
Why?
Case-Control Studies
4
2019
3003
0.120
Why?
Rituximab
1
2016
148
0.120
Why?
Recovery of Function
1
2018
573
0.120
Why?
Sarcoidosis, Pulmonary
1
2015
57
0.120
Why?
Neuroendocrine Cells
1
2015
30
0.120
Why?
Enzyme Inhibitors
2
2016
743
0.120
Why?
Geographic Information Systems
1
2014
37
0.120
Why?
Controlled Clinical Trials as Topic
1
2013
27
0.110
Why?
Phenotype
2
2018
2784
0.110
Why?
Information Dissemination
1
2016
185
0.110
Why?
Sildenafil Citrate
1
2013
57
0.110
Why?
Antifibrinolytic Agents
1
2014
43
0.110
Why?
Self Report
2
2019
695
0.110
Why?
Endpoint Determination
1
2013
68
0.110
Why?
Sulfones
1
2013
97
0.110
Why?
Occupational Exposure
1
2016
255
0.110
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2013
38
0.110
Why?
Adaptation, Psychological
1
2017
545
0.100
Why?
Antibiotics, Antineoplastic
1
2013
110
0.100
Why?
Purines
1
2013
158
0.100
Why?
Patient Dropouts
1
2013
66
0.100
Why?
Young Adult
5
2017
10444
0.100
Why?
Sirolimus
1
2013
181
0.100
Why?
Histocompatibility Antigens Class II
1
2013
350
0.100
Why?
Pulmonary Gas Exchange
1
2012
117
0.100
Why?
Vasodilator Agents
1
2013
302
0.100
Why?
Delivery of Health Care
1
2018
828
0.100
Why?
Health Care Surveys
1
2014
541
0.100
Why?
Minnesota
1
2012
132
0.100
Why?
Exercise Therapy
1
2015
351
0.100
Why?
Fear
1
2014
292
0.090
Why?
Piperazines
1
2013
310
0.090
Why?
Dust
1
2012
84
0.090
Why?
Consensus
1
2013
532
0.090
Why?
United Kingdom
1
2012
226
0.090
Why?
Clinical Trials as Topic
2
2006
926
0.090
Why?
Hydrogen-Ion Concentration
1
2012
507
0.090
Why?
Pilot Projects
2
2015
1360
0.090
Why?
Health Surveys
1
2012
441
0.090
Why?
Anti-Infective Agents
1
2013
219
0.090
Why?
Epidemiologic Methods
1
2010
72
0.090
Why?
Societies, Medical
4
2015
655
0.080
Why?
Sickness Impact Profile
2
2009
50
0.080
Why?
Salivary Glands, Minor
1
2009
8
0.080
Why?
Smoking
2
2017
1382
0.080
Why?
Sjogren's Syndrome
1
2009
41
0.080
Why?
International Cooperation
3
2015
169
0.080
Why?
Hyperplasia
2
2015
163
0.080
Why?
Oximetry
1
2009
79
0.080
Why?
Risk
1
2011
810
0.080
Why?
Europe
3
2015
332
0.080
Why?
Environmental Exposure
1
2012
372
0.080
Why?
Scleroderma, Limited
1
2008
5
0.080
Why?
Depression
2
2019
1133
0.070
Why?
Poisson Distribution
3
2016
71
0.070
Why?
Wound Healing
1
2010
254
0.070
Why?
Sleep Wake Disorders
1
2011
232
0.070
Why?
Bronchoalveolar Lavage Fluid
1
2010
580
0.070
Why?
Comorbidity
2
2017
1447
0.070
Why?
Radiography
2
2016
803
0.070
Why?
Cardiac Catheterization
1
2011
545
0.070
Why?
Models, Statistical
1
2011
595
0.070
Why?
Predictive Value of Tests
2
2009
1791
0.070
Why?
Evidence-Based Medicine
1
2011
662
0.070
Why?
Pericardium
1
2007
50
0.070
Why?
Carbon Monoxide
2
2017
64
0.070
Why?
Physicians
1
2014
765
0.070
Why?
Clinical Trials, Phase III as Topic
2
2016
82
0.070
Why?
Seasons
1
2008
440
0.060
Why?
Medical Records
1
2006
153
0.060
Why?
Regression Analysis
3
2016
945
0.060
Why?
California
1
2005
351
0.060
Why?
Echocardiography
1
2007
569
0.060
Why?
Acute Disease
1
2006
907
0.060
Why?
Data Interpretation, Statistical
2
2018
318
0.050
Why?
Terminology as Topic
1
2005
186
0.050
Why?
Lymphoid Tissue
1
2002
62
0.050
Why?
Patient Selection
1
2005
629
0.050
Why?
Adolescent
3
2017
17800
0.050
Why?
Disease Models, Animal
1
2010
3498
0.040
Why?
Respiratory Therapy
1
2019
19
0.040
Why?
Pulmonary Surfactant-Associated Protein A
1
2019
24
0.040
Why?
Occupations
1
2019
35
0.040
Why?
GTPase-Activating Proteins
1
2019
72
0.040
Why?
Pulmonary Surfactant-Associated Protein C
1
2019
42
0.040
Why?
Exoribonucleases
1
2019
40
0.040
Why?
Blood Gas Analysis
1
2019
70
0.040
Why?
Minimal Clinically Important Difference
1
2018
10
0.040
Why?
ATP-Binding Cassette Transporters
1
2019
122
0.040
Why?
Asthma
1
2011
2021
0.040
Why?
Telomere-Binding Proteins
1
2019
88
0.040
Why?
Patient Advocacy
1
2018
65
0.040
Why?
Education
1
2018
93
0.040
Why?
Watchful Waiting
1
2018
54
0.040
Why?
DNA Helicases
1
2019
133
0.040
Why?
Administrative Claims, Healthcare
1
2017
22
0.040
Why?
Physical Endurance
1
2019
232
0.040
Why?
Forecasting
1
2019
331
0.040
Why?
Mucin-5B
1
2019
184
0.040
Why?
Needs Assessment
1
2019
315
0.040
Why?
Telomerase
1
2019
204
0.040
Why?
Spirometry
1
2017
223
0.030
Why?
Hypersplenism
1
2016
7
0.030
Why?
Leukopenia
1
2016
27
0.030
Why?
Sequence Analysis, DNA
1
2019
722
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2019
437
0.030
Why?
Banking, Personal
1
2016
3
0.030
Why?
Social Participation
1
2016
13
0.030
Why?
Terminal Care
1
2019
212
0.030
Why?
Creatine Kinase
1
2016
75
0.030
Why?
Rheumatoid Factor
1
2017
157
0.030
Why?
Health Care Sector
1
2016
24
0.030
Why?
Death Certificates
1
2016
30
0.030
Why?
Health Services Needs and Demand
1
2017
240
0.030
Why?
Commerce
1
2016
61
0.030
Why?
Arthritis
1
2016
109
0.030
Why?
Metals
1
2016
105
0.030
Why?
International Classification of Diseases
1
2016
116
0.030
Why?
Promoter Regions, Genetic
1
2019
1131
0.030
Why?
Multiple Pulmonary Nodules
1
2015
22
0.030
Why?
Anthropometry
1
2015
183
0.030
Why?
Physical Examination
1
2016
221
0.030
Why?
Genetic Variation
1
2019
868
0.030
Why?
Disease-Free Survival
1
2016
618
0.030
Why?
Alberta
1
2013
10
0.030
Why?
Teaching
1
2016
209
0.030
Why?
Bronchiolitis
1
2015
81
0.030
Why?
Mortality, Premature
1
2013
11
0.030
Why?
Counseling
1
2016
342
0.030
Why?
RNA
1
2019
806
0.030
Why?
Odds Ratio
1
2016
951
0.030
Why?
Genome-Wide Association Study
1
2019
1176
0.030
Why?
Adrenal Cortex Hormones
1
2016
493
0.030
Why?
Drug Therapy, Combination
1
2016
949
0.030
Why?
Inflammation
1
2002
2464
0.030
Why?
Congresses as Topic
1
2013
193
0.030
Why?
Administration, Oral
1
2014
725
0.020
Why?
Age Factors
2
2010
2885
0.020
Why?
Dose-Response Relationship, Drug
1
2016
1836
0.020
Why?
Genetic Predisposition to Disease
1
2019
2090
0.020
Why?
Japan
1
2011
85
0.020
Why?
Antigens, Human Platelet
1
2011
9
0.020
Why?
Latin America
1
2011
68
0.020
Why?
Mental Health
1
2016
559
0.020
Why?
Alanine-tRNA Ligase
1
2009
4
0.020
Why?
Threonine-tRNA Ligase
1
2009
4
0.020
Why?
Psychiatric Status Rating Scales
1
2011
481
0.020
Why?
Animals
1
2010
31565
0.020
Why?
Syndrome
1
2009
330
0.020
Why?
DNA Topoisomerases, Type I
1
2008
16
0.020
Why?
Body Mass Index
1
2015
1957
0.020
Why?
Cell Proliferation
1
2015
2173
0.020
Why?
Lymphocytes
1
2009
327
0.020
Why?
Pulmonary Wedge Pressure
1
2007
64
0.020
Why?
Muscle, Skeletal
1
2015
1468
0.020
Why?
Risk Assessment
1
2015
2958
0.020
Why?
Child
1
2002
18401
0.010
Why?
Nuclear Proteins
1
2008
591
0.010
Why?
Biomarkers
1
2013
3397
0.010
Why?
Pneumonia
1
2008
563
0.010
Why?
Swigris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)